The Optimizer® Smart Mini System

The Optimizer^® system delivers CCM® therapy — the company’s proprietary technology — to the heart, providing an important treatment option for the millions of patients suffering from heart failure.

CCM^® therapy is designed to significantly improve heart contraction, allowing more oxygen-rich blood to be pushed out through the body.¹ CCM^® therapy is indicated to improve six-minute hall walk, quality of life, and functional status of NYHA Class III HF patients who remain symptomatic despite guideline directed medical therapy, are not receiving CRT, and have a left ventricular ejection fraction ranging from 25 to 45 percent. CCM^® is the brand name for cardiac contractility modulation — the non-excitatory electrical pulses delivered by the implantable Optimizer^® device to improve heart contraction. CCM^® therapy sends unique electrical pulses to the heart cells during the absolute refractory period. In doing so, CCM helps the heart contract more forcibly. Impulse Dynamics^® has completed numerous clinical studies, including several randomized controlled trials, the results of which appeared in more than 100 publications in leading medical journals.

Press Releases

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

¹ Khanra D, Manivannan S, Mukherjee A, et al. Incidence and Predictors of Implantable Cardioverter-defibrillator Therapies After Generator Replacement-A Pooled Analysis of 31,640 Patients’ Data. J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5278-5293.

---